Kiromic BioPharma, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KRBP research report →
About the company
Kiromic BioPharma, Inc. is a biotechnology enterprise that harnesses artificial intelligence to advance allogeneic cell therapies. The company's core mission involves crafting multi-indication T-cell treatments, specifically engineered to combat solid tumors by leveraging the innate capabilities of Gamma Delta T cells.
- CEO
- Pietro Bersani CPA,
- IPO
- 2020
- Employees
- 44
- HQ
- Houston, TX, US
Price Chart
- Market Cap
- $214.93K
- P/E
- -0.08
- P/S
- 0.00
- P/B
- -0.17
- EV/EBITDA
- -0.57
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 247.82%
- ROIC
- -1200.10%
- Revenue
- $0 · 0.00%
- Net Income
- $-26,898,000 · -26.32%
- EPS
- $-1.03 · 95.19%
- Op Income
- $-23,774,000
- FCF YoY
- 7.50%
- 52W High
- $3.31
- 52W Low
- $0.05
- 50D MA
- $0.97
- 200D MA
- $1.25
- Beta
- 1.66
- Avg Volume
- 7.89K
Get TickerSpark's AI analysis on KRBP
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 26, 24 | BERSANI PIETRO | buy | 988 |
| Aug 23, 24 | BERSANI PIETRO | buy | 2,500 |
| Aug 20, 24 | Hungerford Brian | buy | 3,742 |
| Aug 19, 24 | Hungerford Brian | buy | 258 |
| Aug 13, 24 | Hungerford Brian | buy | 2,000 |
| Jun 12, 24 | Misajon Pamela | buy | 410 |
| Jun 12, 24 | Misajon Pamela | buy | 1,200 |
| Jun 13, 24 | Hungerford Brian | buy | 1,000 |
| Jun 11, 24 | NAGEL MICHAEL | buy | 1,000 |
| Jun 10, 24 | Misajon Pamela | buy | 1,701 |
Our KRBP coverage
Recent articles, reports, and earnings notes.
No research on KRBP yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate KRBP report →Similar companies
Peers in the same neighborhood.